Literature DB >> 3083507

Induction of macrophage tumoricidal activity by granulocyte-macrophage colony-stimulating factor.

K H Grabstein, D L Urdal, R J Tushinski, D Y Mochizuki, V L Price, M A Cantrell, S Gillis, P J Conlon.   

Abstract

Monocytes are a subpopulation of peripheral blood leukocytes, which when appropriately activated by the regulatory hormones of the immune system, are capable of becoming macrophages--potent effector cells for immune response to tumors and parasites. A complementary DNA for the T lymphocyte-derived lymphokine, granulocyte-macrophage colony-stimulating factor (GM-CSF), has been cloned, and recombinant GM-CSF protein has been expressed in yeast and purified to homogeneity. This purified human recombinant GM-CSF stimulated peripheral blood monocytes in vitro to become cytotoxic for the malignant melanoma cell line A375. Another T cell-derived lymphokine, gamma-interferon (IFN-gamma), also stimulated peripheral blood monocytes to become tumoricidal against this malignant cell line. When IFN-gamma activates monocytes to become tumoricidal, additional stimulation by exogenously added lipopolysaccharide is required. No such exogenous signals were required for the activation of monocytes by GM-CSF.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3083507     DOI: 10.1126/science.3083507

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  103 in total

Review 1.  Mechanism of GM-CSF stimulation of neutrophils.

Authors:  R G Coffey
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

Review 2.  Polypeptides controlling hematopoietic cell development and activation. I. In vitro results.

Authors:  F Herrmann; R Mertelsmann
Journal:  Blut       Date:  1989-03

3.  Granulocyte-macrophage colony-stimulating factor modulates lipopolysaccharide (LPS)-binding and LPS-response of human macrophages: inverse regulation of tumour necrosis factor-alpha and interleukin-10.

Authors:  M Kreutz; B Hennemann; U Ackermann; E Grage-Griebenow; S W Krause; R Andreesen
Journal:  Immunology       Date:  1999-12       Impact factor: 7.397

4.  Immune mobilization of autologous blood progenitor cells: direct influence on the cellular subsets collected.

Authors:  Kenneth R Meehan; Laleh Talebian; Jillian Wu; John M Hill; Zbigniew M Szczepiorkowski; Charles L Sentman; Marc S Ernstoff
Journal:  Cytotherapy       Date:  2010-09-27       Impact factor: 5.414

5.  Dengue virus infection of human skin fibroblasts in vitro production of IFN-beta, IL-6 and GM-CSF.

Authors:  I Kurane; J Janus; F A Ennis
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

6.  Effect of interferon-gamma priming on the activation of murine peritoneal macrophages to tumouricidal state by cisplatin, IL-1, and tumour necrosis factor (TNF): production of IL-1 and TNF.

Authors:  A Sodhi; R K Singh; S M Singh
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

7.  Adjuvant GM-CSF improves survival in high-risk stage iiic melanoma: a single-center Study.

Authors:  Travis E Grotz; Lisa Kottschade; Emily S Pavey; Svetomir N Markovic; James W Jakub
Journal:  Am J Clin Oncol       Date:  2014-10       Impact factor: 2.339

8.  Granulocyte-monocyte-colony-stimulating factor augments the cytotoxic capacity of lymphocytes and monocytes in antibody-dependent cellular cytotoxicity.

Authors:  G Masucci; P Wersäll; P Ragnhammar; H Mellstedt
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

9.  Regulation of murine macrophage function by IL-4: IL-4 and IFN-gamma differentially regulate macrophage tumoricidal activation.

Authors:  K Suk; S D Somers; K L Erickson
Journal:  Immunology       Date:  1993-12       Impact factor: 7.397

10.  Complement drives Th17 cell differentiation and triggers autoimmune arthritis.

Authors:  Motomu Hashimoto; Keiji Hirota; Hiroyuki Yoshitomi; Shinji Maeda; Shin Teradaira; Shuji Akizuki; Paz Prieto-Martin; Takashi Nomura; Noriko Sakaguchi; Jörg Köhl; Birgitta Heyman; Minoru Takahashi; Teizo Fujita; Tsuneyo Mimori; Shimon Sakaguchi
Journal:  J Exp Med       Date:  2010-05-10       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.